glp 1 drugs injection Do the new GLP-1 “slimming” deliver better pouch performance? - J Pouch support charity At-home GLP-1 Injections: A How-to

theyre now the public faces of GLP-1 medications

Current evidence suggests that GLP-1 medications, when used with appropriate patient selection and monitoring, likely do not pose significant long-term threats to vision for most patients and may contribute to better overall ocular outcomes through improved metabolic control

While anabolic or anti-catabolic agents - especially myostatin/activin pathway inhibitors - show promise, translation into improved patient-centered outcomes is not yet established (Table 3)

Blackman et al

Several studies have linked DPP4 antagonists to recently diagnosed RA patients

2000;24(Suppl 2):S109S112